DSIP is a synthetic nonapeptide originally isolated from the cerebral venous blood of rabbits in a state of induced sleep. It is utilized in neuroscience research to study the induction of delta-wave EEG activity and the modulation of the hypothalamic-pituitary-adrenal (HPA) axis. For research use only.
DSIP is a highly specialized nonapeptide sequence synthesized to explore the endogenous mechanisms of sleep induction and circadian rhythm stability. Unlike sedative compounds that induce a pharmacological “knockout” state, DSIP is researched for its ability to facilitate natural sleep architecture by increasing delta-frequency oscillations in the brain. This reagent allows researchers to observe the regulation of the neuroendocrine system, specifically the peptide’s interaction with luteinizing hormone (LH) and somatotropin levels. Supplied as a stable, lyophilized powder, it is intended strictly for laboratory research; it is not for human or veterinary administration.
